PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsMeglumine
Meglumine
Dibasic, Monobasic, Monohydrate, Phosphate (meglumine) is a small molecule pharmaceutical. Meglumine was first approved as Sodium phosphates in plastic container on 1983-05-10. It is used to treat aids-related opportunistic infections, cutaneous leishmaniasis, and visceral leishmaniasis in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
skin and connective tissue diseasesD017437
immune system diseasesD007154
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Calcium
+
Meglumine
+
Metrizoic acid
Tradename
Company
Number
Date
Products
ISOPAQUE 280GE HealthcareN-017506 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
baxdelaNew Drug Application2025-08-01
clariscanANDA2025-05-19
conrayNew Drug Application2023-05-11
cysto-conrayNew Drug Application2010-07-08
cysto-conray iiNew Drug Application2020-12-31
cystografinNew Drug Application2018-04-15
cystografin diluteNew Drug Application2018-10-02
diatrizoate meglumine and diatrizoate sodiumANDA2025-02-19
dotaremNew Drug Application2025-03-14
gadoterate meglumineANDA2025-04-16
Show 7 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
cutaneous leishmaniasis—D016773B55.1
visceral leishmaniasis—D007898B55.0
aids-related opportunistic infections—D017088—
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Sodium Phosphate, Dibasic, Anhydrous / Sodium Phosphate, Monobasic, Monohydrate, Osmoprep, Salix Pharms
76870752028-06-22DS, DP
ATC Codes
P: Antiparasitic products, insecticides and repellents
— P01: Antiprotozoals
— P01C: Agents against leishmaniasis and trypanosomiasis
— P01CB: Antimony compounds for treatment of leishmaniasis and trypanosomiasis
— P01CB01: Meglumine antimonate
HCPCS
Code
Description
A9575
Injection, gadoterate meglumine, 0.1 ml
A9577
Injection, gadobenate dimeglumine (multihance), per ml
A9578
Injection, gadobenate dimeglumine (multihance multipack), per ml
Clinical
Clinical Trials
145 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients——————1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMeglumine
INNmeglumine
Description
N-methylglucamine is a hexosamine that is D-glucitol in which the hydroxy group at position 1 is substituted by the nitrogen of a methylamino group. A crystalline base, it is used in preparing salts of certain acids for use as diagnostic radiopaque media, while its antimonate is used as an antiprotozoal in the treatment of leishmaniasis. It is a hexosamine and a secondary amino compound.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
Identifiers
PDB—
CAS-ID6284-40-8
RxCUI—
ChEMBL IDCHEMBL1200570
ChEBI ID59732
PubChem CID8567
DrugBank—
UNII ID6HG8UB2MUY (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
Baxdela – Melinta Therapeutics /new/
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 10,906 documents
View more details
Safety
Black-box Warning
Black-box warning for: Baxdela, Clariscan, Conray, Cysto-conray, Cysto-conray ii, Dotarem, Gadoterate meglumine
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
12,248 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use